Combinational strategy | Malignancy | Reference/Identifier |
---|---|---|
Erlotinib+Gemcitabine | Pancreatic cancer | |
Lapatinib+Capecitabine | Breast cancer | |
Nintedanib+Docetaxel | NSCLC | [106] |
Erlotinib+Everolimus | Head and Neck squamous cell carcinoma | [141] |
Erlotinib+Carboplatin | Ovarian cancer | [142] |
Erlotinib+Topotecan | Solid tumor | [143] |
Lapatinib+Epirubicin | Breast cancer | NCT 00753207 |
Sorafenib+Paclitaxel | Solid tumor | NCT 00572078 |